IRIS - Res&Arch Institutional Research Information System - Research & Archive

BELLOMO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 719
AS - Asia 711
EU - Europa 402
SA - Sud America 125
AF - Africa 19
OC - Oceania 6
Totale 1.982
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 697
SG - Singapore 311
HK - Hong Kong 128
IT - Italia 111
CN - Cina 109
BR - Brasile 108
DE - Germania 57
IE - Irlanda 57
RU - Federazione Russa 49
KR - Corea 48
VN - Vietnam 39
FI - Finlandia 27
GB - Regno Unito 23
IN - India 17
JP - Giappone 17
CA - Canada 14
NL - Olanda 14
RO - Romania 11
PL - Polonia 10
FR - Francia 8
AT - Austria 7
ES - Italia 7
IQ - Iraq 7
ZA - Sudafrica 7
AR - Argentina 6
BD - Bangladesh 6
NZ - Nuova Zelanda 5
SE - Svezia 5
TR - Turchia 4
UZ - Uzbekistan 4
CO - Colombia 3
ID - Indonesia 3
LT - Lituania 3
PK - Pakistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
VE - Venezuela 3
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
MD - Moldavia 2
MX - Messico 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
GM - Gambi 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
PA - Panama 1
PG - Papua Nuova Guinea 1
PT - Portogallo 1
RE - Reunion 1
SD - Sudan 1
TJ - Tagikistan 1
TW - Taiwan 1
ZM - Zambia 1
Totale 1.982
Salva come PNG Salva come JPEG
Città #
Singapore 210
Hong Kong 127
Chandler 83
Ashburn 69
Dublin 57
Boardman 56
Seoul 48
Los Angeles 40
Perugia 36
Santa Clara 32
Beijing 24
Munich 23
Piscataway 23
Moscow 21
New York 20
San Mateo 18
Tokyo 16
Ho Chi Minh City 13
The Dalles 13
Altamura 12
Dallas 12
Helsinki 11
São Paulo 11
Turku 11
Brooklyn 10
Timisoara 10
Lawrence 9
Medford 9
Nuremberg 9
Princeton 9
Rome 9
Wilmington 9
Chennai 8
Milan 8
Warsaw 8
Denver 7
Hefei 7
Boston 6
Hanoi 6
Houston 6
London 6
Montreal 6
Phoenix 6
Redmond 6
Andover 5
Auckland 5
Columbus 5
Dong Ket 5
Falkenstein 5
Falls Church 5
Lappeenranta 5
Manchester 5
Poplar 5
Stockholm 5
Vienna 5
Amsterdam 4
Atlanta 4
Da Nang 4
Johannesburg 4
Orem 4
Secaucus 4
Baghdad 3
Chicago 3
Curitiba 3
Des Moines 3
Groningen 3
Mumbai 3
Newark 3
Newquay 3
Rio de Janeiro 3
Tashkent 3
Toronto 3
Turin 3
Ankara 2
Belém 2
Betim 2
Brasília 2
Brixen 2
Charlotte 2
Córdoba 2
Florence 2
Frankfurt am Main 2
Genoa 2
Goiânia 2
Haiphong 2
João Pessoa 2
Miami 2
Minneapolis 2
Nairobi 2
Pittsburgh 2
Porto Alegre 2
Providence 2
Redwood City 2
Reykjavik 2
Santo André 2
Sargodha 2
Seattle 2
Shanghai 2
Thái Bình 2
Tianjin 2
Totale 1.309
Salva come PNG Salva come JPEG
Nome #
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 121
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 103
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 90
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 86
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 73
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 70
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 70
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 63
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview 62
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? 61
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 60
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 59
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid 58
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 58
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 56
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 55
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 55
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 53
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 52
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 51
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease 51
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 50
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 49
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 49
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 48
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 46
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 43
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 43
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 42
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 42
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 42
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 41
Lipoproteins and α-synuclein in cerebrospinal fluid in Parkinson's disease: "Dangerous liaisons" on the road to neurodegeneration? 37
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 32
Research advancement in fluid biomarkers for Parkinson's disease 29
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approach 23
Totale 2.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.409
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 3 0 0 0 0 3 7
2021/202264 1 10 2 0 2 5 4 13 4 7 7 9
2022/2023259 9 60 8 17 19 22 0 20 91 1 8 4
2023/2024223 10 16 12 6 7 1 34 6 49 11 27 44
2024/2025680 7 55 51 37 54 44 55 66 115 43 101 52
2025/2026764 95 119 62 197 208 83 0 0 0 0 0 0
Totale 2.023